Trudeau
Showing 1–2 of 2 transcripts.
- The Economist25 min
It’s no longer Trudeau: Canada’s PM resigns
Trudeau, Jason Palmer, Rob, Sophie Pedder, Shailesh Chitnas
Canadian Prime Minister Justin Trudeau announced his resignation following a decade of governance marked by significant electoral decline and internal conflict, setting the stage for a leadership succession race and an upcoming election centered on economic instability and foreign tariff threats. Meanwhile, the French satirical newspaper *Charlie Hebdo* marked the tenth anniversary of the deadly 2015 attack by reaffirming its provocative editorial stance from a secure location, even as public support for its right to caricature religious figures wanes amid a shifting cultural landscape. In the pharmaceutical sector, Artificial Intelligence is poised to disrupt an industry struggling with soaring development costs by accelerating molecular design and reducing timelines, though current clinical success rates remain constrained by the inherent complexity of human biology.
- All-In Podcast1h 30m
E68: Trudeau invokes emergency powers, Bitcoin vs. government, Tiger Global's new strategy and more
Trudeau, Fauci, Paul Graham, Calacanis, Friedberg, Chamath Palihapitiya, David Sacks
Prime Minister Justin Trudeau invoked Canada's *Emergencies Act* to freeze protest-linked assets, drawing swift legal challenges from the Civil Liberties Association and predictions from Chamath Palihapitiya regarding accelerated adoption of decentralized currencies. Simultaneously, San Francisco voters recalled three school board members in a landslide driven by educational policy grievances, prompting the Board of Supervisors to consider recall reform legislation. In the financial sector, major venture capital firms like Tiger Global are pivoting from late-stage valuations to early-stage deals as market multiples compress, while medical researchers advance gene-editing therapies to cure HIV without the risks of full bone marrow transplants.